Month: December 2023

Click here for the CFNews press release.

 

The Toulouse-based healthcare group Hygie 31, advised by Joffe & Associés (Christophe Joffe, Camille Malbezin and Oriana Castelli), is acquiring Distrimed, an online retailer of medical equipment and medical devices, in order to complete and consolidate its offerings on the market.

 

In 2023, Hygie31 will continue its expansion with the acquisition of Distrimed, a subsidiary of Bastide le Confort médical. This move reflects the determination of the group that owns the Lafayette chain to anticipate demographic trends and meet the growing need for home care.

 

“We are going to strengthen Distrimed and support its development. The company will continue to develop its BtoB activities and will become our online distribution base for medical equipment”. – Hervé Jouves, Chairman of Hygie 31.

 

With the integration of Distrimed, Hygie31’s digital offering will be enhanced by more than 6,000 references, including 20 new product families. This expansion will also open up access to healthcare professionals such as doctors and nurses.

 

Hygie 31 is acquiring all the shares in Distrimed, carrying out the transaction entirely in cash. This strategic takeover has generated enthusiasm within the network of brands, including pharmacies, parapharmacies, opticians and medical devices, which sees this transaction as a major opportunity. With this acquisition, the group headed by Hervé Jouve consolidates its presence while strengthening its digital activities, led by Dhygietal, the leader in online parapharmacy with sales of €80 million, as emphasised by Hervé Jouve, Chairman of Hygie 31.

Find all the official information on CFNews here.

 

Joffe & Associés (Thomas Saltiel, Charlotte Viandaz and Rudy Diamant) is advising BPI France and 360 Capital on the fundraising of Callyope, a company offering solutions combining voice and AI for the detection of mental disorders and illnesses such as schizophrenia, bipolar disorders and severe depression.

 

In a world where one person in eight – some 970 million people – has a severe mental disorder, the issue of mental health is more important than ever. It was against this backdrop that Callyope managed to raise €2.2 million this summer from investors including 360 Capital, Bpifrance Investissement with the support of the Digital Venture Fund, No Label Ventures (an Anglo-Saxon venture capital fund set up this year by Ramzi Rafih, formerly of KKR), and business angels such as Thomas Clozel (Owkin) and Adrien Montfort (Sorare). This fund-raising enabled the company to reach a valuation of €6.55 million.

 

“Nearly 1% of the population suffers from schizophrenia and 2 to 3% from bipolar disorder. These illnesses are very often chronic, and almost half of patients hospitalised relapse within twelve months”, explains Martin Denais, co-director of Callyope.

 

Callyope is now working in collaboration with well-known hospitals to develop its solutions and expand its database. The company, which has positioned itself in the mental health market representing a cost of around €600 billion a year in the European Union according to the Court of Auditors, intends to test its software on several hundred patients from the beginning of next year to demonstrate its effectiveness. Designed for monitoring rather than diagnosis, the tool is intended to be marketed to Centres Médico-Psychologiques (CMP). The start-up currently has nine employees, and plans at least a year of R&D before reaching the stage of marketing its analysis solutions.